{"id":"NCT00932893","sponsor":"Pfizer","briefTitle":"An Investigational Drug, PF-02341066 Is Being Studied Versus Standard Of Care In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene","officialTitle":"Phase 3, Randomized, Open-label Study Of The Efficacy And Safety Of Pf-02341066 Versus Standard Of Care Chemotherapy (Pemetrexed Or Docetaxel) In Patients With Advanced Non-small Cell Lung Cancer (Nsclc) Harboring A Translocation Or Inversion Event Involving The Anaplastic Lymphoma Kinase (Alk) Gene Locus","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-09","primaryCompletion":"2012-03","completion":"2016-01","firstPosted":"2009-07-03","resultsPosted":"2013-06-06","lastUpdate":"2017-01-02"},"enrollment":347,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Carcinoma, Non-Small-Cell Lung"],"interventions":[{"type":"DRUG","name":"PF-02341066","otherNames":[]},{"type":"DRUG","name":"Pemetrexed","otherNames":[]},{"type":"DRUG","name":"Docetaxel","otherNames":[]}],"arms":[{"label":"PF-02341066","type":"EXPERIMENTAL"},{"label":"Pemetrexed or Docetaxel","type":"ACTIVE_COMPARATOR"}],"summary":"This is a Phase 3 trial comparing the safety and anti-tumor activity of PF-02341066 versus pemetrexed or docetaxel in patients with advanced non-small cell lung cancer with specific gene profile involving the ALK gene after failure of one previous chemotherapy regimen that included one platinum drug.","primaryOutcome":{"measure":"Progression-Free Survival (PFS)","timeFrame":"Randomization until progressive disease (PD) or initiation of antitumor therapy in the absence of PD or death, assessed every 6 weeks (up to 112 weeks)","effectByArm":[{"arm":"Crizotinib","deltaMin":7.7,"sd":null},{"arm":"Chemotherapy","deltaMin":3,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":2},"locations":{"siteCount":264,"countries":["United States","Australia","Brazil","Bulgaria","Canada","China","France","Germany","Greece","Hong Kong","Hungary","Ireland","Italy","Japan","Netherlands","Poland","Russia","South Korea","Spain","Sweden","Taiwan","United Kingdom"]},"refs":{"pmids":["30822515","30652510","28373069","27130468","25624436","25436806","23724913","23169500"],"seeAlso":["https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=A8081007&StudyName=An%20Investigational%20Drug%2C%20PF-02341066%20Is%20Being%20Studied%20Versus%20Standard%20Of%20Care%20In%20Patients%20With%20Advanced%20Non-Small%20Cell%20Lung%20Cancer%20Wit"]},"adverseEventsSummary":{"seriousAny":{"events":80,"n":172},"commonTop":["Nausea","Diarrhoea","Constipation","Vomiting","Fatigue"]}}